⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BMY News
Bristol-Myers Squibb Co.
Overhaul expands exclusive partnership with BNSF to strengthen freight security across its network
prnewswire.com
MSFT
BMY
Medical Marijuana Clinical Trial Landscape Expands as 60+ Leading Companies Accelerate Drug Development | DelveInsight
globenewswire.com
TLRY
IGC
JNJ
LLY
BMY
GSK
PFE
ABBV
Global Critical Infrastructure Protection (CIP) Market Forecast, 2026-2031 | AI, Digital Twins, and OT Security Drive Growth to USD 206.31 Billion
globenewswire.com
FCEL
FTNT
CSCO
LMT
GD
NOC
HON
SNOW
GE
T
VZ
AVGO
AMD
NVDA
MSFT
GOOG
AMZN
IBM
PANW
CRWD
DDOG
ETSY
PLTR
SMCI
QCOM
INTC
MU
AMAT
LRCX
ASML
ADI
TXN
MRVL
NXPI
ON
STM
INFY
ACN
HPQ
DELL
CDNS
SNPS
MCHP
AEHR
TER
AMKR
WDC
SE
BABA
JD
NTES
PDD
IQ
BEKE
RBLX
EXAS
REGN
GILD
BMY
AMGN
VRTX
AZN
MRK
LLY
SNY
ABBV
BIIB
XRAY
ISRG
MDLZ
ADM
KHC
PEP
KO
MCD
SBUX
YUM
CMG
NKE
LULU
BBY
TJX
HD
LOW
COST
WMT
GOOGL
AAPL
META
NFLX
DIS
CMCSA
S
BA
AIR
TH
TENB
CLAR
BAC
Phanes Therapeutics to participate in Longwood Healthcare Leaders Boston CEO, November 2-3, 2026
prnewswire.com
INCY
MRNA
ALNY
BMY
BIIB
BlackLine Honors Global Enterprise Leaders Transforming Financial Operations
globenewswire.com
BL
BKNG
BMY
JHX
USFD
Kraft Heinz, T-Mobile, Otis, Hasbro and Citi Named Among Newsweek’s America’s Greenest Companies 2027
globenewswire.com
KHC
TMUS
OTIS
HAS
BMY
AMAT
More Than 125 Technology Leaders Registered for HMG Strategy's 19th Annual Greenwich C-Level Technology Leadership Summit on October 15
globenewswire.com
PEP
MA
BMY
CHTR
CSCO
CRWD
EL
Bristol Myers Squibb Announces Positive Topline Results from the Interim Analysis of Phase 3 ACTION-1 for RYZ101, RayzeBio’s Radiopharmaceutical Therapy, in Patients with GEP-NETs
businesswire.com
BMY
Bristol Myers Squibb Announces Phase 3 ALOFT-IPF Trial Evaluating Admilparant in Adults with Idiopathic Pulmonary Fibrosis Met Primary Endpoint
businesswire.com
BMY
Active Pharmaceutical Ingredients (API) Market 2026-2034: Global Size, Share, Growth and Company Analysis | Generics, Biologics and Outsourcing Drive Value to $400.94 Billion
globenewswire.com
TEVA
BIIB
PFE
BMY
LLY
MRK
ABBV